PEGASO – Fit for Future
The PEGASO team explain the challenges to healthcare obesity represents and how the Fit for Future project aims to tackle them
Novaramed – Novel medication for neuropathic pain
As neuropathic pain increasingly becomes a global health issue, Novaramed is developing a treatment for chronic pain caused by nervous system damage
Alzheimer’s Disease as a spectrum disorder
When it comes to Alzheimer's Disease one size does not fit all. It should be considered a spectrum disorder, with precision medicine a key part of treatment
What are the options for personalised muscle rehabilitation?
Martin Fluck from Balgrist University Hospital outlines options for personalised muscle rehabilitation and research on molecular and cellular mechanisms
Drug development for neurodegenerative diseases
Professor Duncan McHale, Head Global Exploratory Development at UCB discusses the challenge of developing drugs to treat neurodegenerative diseases
Acute respiratory distress syndrome: complex and under-recognised
Matthieu Jabaudon, Université Clermont Auvergne outlines the complexities of acute respiratory distress syndrome and opportunities for precision medicines
Hand hygiene and beyond: its influence on infection control
Hygiena International highlights how effective hand hygiene and cleanliness in a healthcare environment is only one simple test away
Providing mental health services in the Palatinate
Pfalzklinikum shares its work as a mental health services provider and explains why wellbeing is vital for everyone, including a firm's own staff
Targeted drugs: Improving the lives of cancer patients
On Target Laboratories' Dr Sumith A. Kularatne shares his research into targeted drugs and notes the difference this treatment makes to cancer patients
Viruses and cancer: Should we be more afraid?
During the past 30 years it has become exceedingly clear that several viruses play significant roles in the development of various cancers in humans
Blue sky research: Is it worth the investment?
In his latest ebook, Professor Colin Suckling of the University of Strathclyde tackles the question: Is there any evidence that the cumulative output of research over the last 50 years has been valuable?
Redefining child health for the 21st Century: UIC Pediatrics’ strategic plan
The Department of Pediatrics at the University of Illinois, Chicago is working on redefining child health for the 21st Century
Innovative strategies to address the mental health crisis
Dr Benjamin Van Voorhees from the Department of Paediatrics in the University of Illinois at Chicago, outlines innovative strategies to tackle the mental health crisis in the US
Hygiena: Diagnose and monitor hygiene across the hospital
The purpose of this document is to address the issues around the measurement of cleaning and its impact on the control of hygiene, infections, and the quality and cost of service delivery.
Associative electronic health record software systems
As technology advances, the benefits can be seen in all different sectors. The healthcare sector, in particular, has benefited greatly from digitalisation and technology innovations. One of the key developments is the electronic health record (EHR).
CECAD: Interplay between immunity and metabolism
Immunity can be defined as the ability of an organism to defend itself against invading microbes (bacteria, fungi and viruses) and the cells of its own origin which show abnormalities (e.g. cancerous cells).
The eNuk program: Climate Change Impacts on Inuit Health
The Canadian North is experiencing intense and rapid socio-cultural stresses resulting from various shifts in the environment, including climate change and resource extraction and development.
It’s a Question of Balance – Broadening Concepts of Drug Discovery
Professor Colin Suckling discusses drug discovery and how a linear approach is no longer relevant… Since the 1960s it’s been accepted that the way to discover new drugs is to take a well-characterised disease with a good understanding of the biological cause of the disease.
Mathematical Modeling of Drug Delivery via Nanoparticles in Cancer Treatment
Cancer is a complex and heterogeneous disease. Despite all efforts to fight cancer, it continues to impact every segment of society. For example, many patients fail conventional cancer therapies, including chemotherapy, radiation, and surgery; and it is still difficult for physicians to predict a treatment outcome with certainty.
Neurodegenerative diseases
Neurodegenerative diseases are a growing global challenge as medical advances ensures more individuals live longer. By 2020 there will be more than 40 million individuals in the world with Alzheimer’s disease and by 2040, without the development of truly disease modifying drugs this will be more than 80 million.
